- Citations, last 5 years
- 572
- Works, last 5 years
- 17
- h-index
- 32
- Scientists listed
- 0
- Grants since 2016
- 6
Grants received
2026 · research · Parkinson’s Disease Therapeutics Pipeline Program -Pre-Clinical
CSM-101 TRPML1 Agonist for Parkinson’s Disease
Leon Murphy · Casma Therapeutics (United States) · funded by Michael J. Fox Foundation for Parkinson's Research
2025 · research · T2T Validation - Endolysosomal Targets
Development of in Vivo Biomarkers for TRPML1 Target Engagement and Analysis of Therapeutics
Leon Murphy · Casma Therapeutics (United States) · funded by Michael J. Fox Foundation for Parkinson's Research
2021–2023 · research · R43
Discovery of Small Molecules as Antimalarial Agents
Shuren Zhu · Casma Therapeutics (United States) · funded by National Institutes of Health
2019 · research · Therapeutic Pipeline Program
Development of a Novel TRPML1 Activator for Parkinson’s Disease
Daniel S. Ory · Casma Therapeutics (United States) · funded by Michael J. Fox Foundation for Parkinson's Research
2018–2019 · research · R43
Development of Natural Product Derivatives as Antiprotozoal Agents
Shuren Zhu · Casma Therapeutics (United States) · funded by National Institutes of Health
2017–2018 · research · R43
Evaluation of Natural Products and Derivatives as Antimalarial Agents
Shuren Zhu · Casma Therapeutics (United States) · funded by National Institutes of Health